|
SKŁADNIKI AKTYWNE |
E.W.A. -01 |
|
|
|
Porcja jednorazowa |
2 kapsułki |
|
|
|
Ilość porcji w opakowaniu |
28 |
|
|
|
Opakowanie |
56 kapsułek |
|
|
|
Zawartość |
w 1 porcji (2 kapsułki) |
zaw: |
% DZ |
|
|
AKTYWNE SKŁADNIKI PREPARATU |
|
|
|
|
1,3-dimethyl-7H-purine-2,6-dione (teofilina) |
|
|
|
|
3,7-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione (teobromina) |
|
|
|
|
1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione (kofeina) |
|
|
|
|
3,7-dimethylocta-2,6-dienal (citral) |
|
|
|
|
3,7-Dimethyloct-6-en-1-ol (cytronelol = citronelool) |
|
|
|
|
Bakozyd (bacoside) |
|
|
|
|
5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one (apigenina) |
|
|
|
|
8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid (brahmic acid) |
|
|
|
|
(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol (protopanaxadiol) |
|
|
|
|
6,20-Bis(?-D-glucopyranosyl)-(3?,6?,12?,20S)-3,6,12,20-tetrahydroxydammar-24-ene (ginsenozyd A2): |
|
|
|
|
(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol (protopanaxatriol) |
|
|
|
|
|
|
|